ReachMD

Episodes 1-15 of 102

• • 

    

    David M. Simpson, MD

    Peer

  • 

    

    Jon T. Gertken, MD

    Peer

  • 

    

    Stephanie Simon, NP

    Peer

  2

  

  RestartResume

  Best Practices for Administering Prescription Strength Capsaicin for Painful DPN of the Feet

  Best Practices for Administering Prescription Strength Capsaicin for Painful DPN of the Feet

• • 

    

    David M. Simpson, MD

    Peer

  • 

    

    Serge Perrot, MD, PhD

    Peer

  2

  

  RestartResume

  Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet

  Addressing Questions Regarding Long-Term Treatment with a TPRV1 Agonist for Painful DPN of the Feet

• • 

    

    David M. Simpson, MD

    Peer

  • 

    

    Rory Abrams, MD

    Peer

  4

  

  RestartResume

  Capsaicin 8% Topical System: An Advancement in the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet

  Capsaicin 8% Topical System: An Advancement in the Treatment of Painful Diabetic Peripheral Neuropathy of the Feet

• • 

    

    Kevan C. Herold, MD

    Peer

  • 

    

    Andrea Steck, MD

    Peer

  • 

    

    Anette Gabriele Ziegler, MD

    Peer

  0

  

  RestartResume

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  Changing Treatment Paradigms in Type 1 Diabetes:  Role of Anti-CD3 Targeted Therapy -

  Screening for Islet Autoantibodies in Children and Adolescents to Prevent/Delay T1D

  0.50 credits

• • 

    

    Rachel Pessah-Pollack, MD

    Peer

  • 

    

    Peter McCullough, MD

    Peer

  1

  

  RestartResume

  The CRM Systems and the Continuum of Disease Risk

  The CRM Systems and the Continuum of Disease Risk

• • 

    

    Eden Miller, DO

    Peer

  • 

    

    James O’Keefe, MD

    Peer

  1

  

  RestartResume

  Close to the Heart: Assessing Cardiovascular Risk Factors in Our Patients With Type 2 Diabetes

  Close to the Heart: Assessing Cardiovascular Risk Factors in Our Patients With Type 2 Diabetes

• • 

    

    Peter McCullough, MD

    Peer

  • 

    

    Rachel Pessah-Pollack, MD

    Peer

  1

  

  RestartResume

  Morbidity of Cardio-Renal-Metabolic (CRM) Disorders: Multifaceted Risk Factor Management

  Morbidity of Cardio-Renal-Metabolic (CRM) Disorders: Multifaceted Risk Factor Management

• • 

    

    Peter McCullough, MD

    Peer

  • 

    

    Rachel Pessah-Pollack, MD

    Peer

  1

  

  RestartResume

  Mortality of Cardio-Renal-Metabolic (CRM) Disorders: The Benefits of a Collaborative Care Approach

  Mortality of Cardio-Renal-Metabolic (CRM) Disorders: The Benefits of a Collaborative Care Approach

• • 

    

    Eden Miller, DO

    Peer

  • 

    

    James O’Keefe, MD

    Peer

  1

  

  RestartResume

  Close to the Heart: The Impact of Cardiovascular Disease on Patients With Type 2 Diabetes

  Close to the Heart: The Impact of Cardiovascular Disease on Patients With Type 2 Diabetes

• • 

    

    Eden Miller, DO

    Peer

  • 

    

    James O’Keefe, MD

    Peer

  1

  

  RestartResume

  Close to the Heart: The Increasing Prevalence of Type 2 Diabetes and Associated Comorbidities

  Close to the Heart: The Increasing Prevalence of Type 2 Diabetes and Associated Comorbidities

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Kevin Griffiths, MD, MPH, FASN

    Peer

  • 

    

    Anna Chambers, MS, RD, LDN

    Peer

  1

  

  RestartResume

  The Pathophysiology of sHPT: Understanding the Calcium-Sensing Receptor Pathway

  The Pathophysiology of sHPT: Understanding the Calcium-Sensing Receptor Pathway

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Colleen Guffee, MS, RD, LD

    Peer

  • 

    

    Jillian Golan, RD, LDN

    Peer

  0

  

  RestartResume

  Management of sHPT: A Dietitian's Perspective

  Management of sHPT: A Dietitian's Perspective

• • 

    

    John J. Russell, MD

    Peer

  • 

    

    Kevin Griffiths, MD, MPH, FASN

    Peer

  • 

    

    Colleen Guffee, MS, RD, LD

    Peer

  • 

    

    Linda Roberto, MA, RD, LDN

    Peer

  1

  

  RestartResume

  Get the Facts About Reimbursement for a Secondary Hyperparathyroidism Treatment Option

  Get the Facts About Reimbursement for a Secondary Hyperparathyroidism Treatment Option

• • 

    

    Brett Nowlan, MD

    Peer

  6

  

  RestartResume

  Recognizing Metabolic Dysfunction as a Driver of Cardiovascular Risk

  Recognizing Metabolic Dysfunction as a Driver of Cardiovascular Risk

• • 

    

    John Buse, MD, PhD

    Peer

  0

  

  RestartResume

  Debating Diabetic Diets: Considering Keto for Patients with Diabetes

  Debating Diabetic Diets: Considering Keto for Patients with Diabetes

• 1
• 2
• 3
• …
• 6
• 7
• Next